Items where authors include "Carter, M."
Article
Carter, M. orcid.org/0000-0003-0683-3874 (2025) Relational Equality for Extended Minds. Synthese. ISSN 0039-7857 (In Press)
Aalbers, J., Akerib, D.S., Al Musalhi, A.K. orcid.org/0009-0004-3067-9939 et al. (205 more authors) (2025) Measurements and models of enhanced recombination following inner-shell vacancies in liquid xenon. Physical Review D, 112 (1). 012024. ISSN 2470-0010
Aalbers, J., Akerib, D.S., Musalhi, A.K.A. et al. (215 more authors) (2025) Dark matter search results from 4.2 tonne-years of exposure of the LUX-ZEPLIN (LZ) experiment. Physical Review Letters, 135 (1). 011802. ISSN 0031-9007
Aalbers, J., Akerib, D.S., Al Musalhi, A.K. et al. (205 more authors) (2025) New constraints on cosmic ray-boosted dark matter from the LUX-ZEPLIN experiment. Physical Review Letters, 134 (24). 241801. ISSN 0031-9007
Aalbers, J., Akerib, D.S., Musalhi, A.K.A. et al. (216 more authors) (2025) First constraint on atmospheric millicharged particles with the LUX-ZEPLIN experiment. Physical Review Letters, 134 (24). 241802. ISSN 0031-9007
Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099
Aalbers, J., Abe, K., Adrover, M. et al. (436 more authors) (2025) Neutrinoless double beta decay sensitivity of the XLZD rare event observatory. Journal of Physics G: Nuclear and Particle Physics, 52 (4). 045102. ISSN 0954-3899
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370
Bentham, R., Jones, T.P. orcid.org/0000-0003-2748-0780, Black, J.R.M. orcid.org/0000-0001-5598-7752 et al. (327 more authors) (2025) ImmuneLENS characterizes systemic immune dysregulation in aging and cancer. Nature Genetics, 57. pp. 694-705. ISSN 1061-4036
Carter, M. orcid.org/0000-0003-0683-3874 (2025) On the Quality of Relational Justice. Analytic Philosophy. ISSN 2153-9596
Carter, M. orcid.org/0000-0003-0683-3874 (2025) Correction: The Indirect Approach: Towards Non-Dominating Dementia Care. Res Publica. ISSN 1356-4765
Biswas, D. orcid.org/0000-0001-9141-5188, Liu, Y.-H. orcid.org/0009-0001-1508-5276, Herrero, J. orcid.org/0000-0001-7313-717X et al. (267 more authors) (2025) Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma. Nature Cancer, 6. pp. 86-101. ISSN 2662-1347
Aalbers, J., Akerib, D.S., Al Musalhi, A.K. orcid.org/0009-0004-3067-9939 et al. (202 more authors) (2025) Two-neutrino double electron capture of 124Xe in the first LUX-ZEPLIN exposure. Journal of Physics G: Nuclear and Particle Physics, 52 (1). 015103. ISSN 0954-3899
Black, J.R.M. orcid.org/0000-0001-5598-7752, Bartha, G., Abbott, C.W. et al. (277 more authors) (2025) Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma. Nature Medicine, 31 (1). pp. 70-76. ISSN 1078-8956
Slevin, F. orcid.org/0000-0002-7176-904X, Alexander, S., Brown, S.R. orcid.org/0000-0002-7975-7537 et al. (20 more authors) (2024) Pelvis or involved node treatment: eradicating recurrence in prostate cancer (POINTER-PC) – study protocol paper for a phase III multicentre, open-label randomised controlled trial. BMJ Open, 14. e095560. ISSN 2044-6055
Slevin, F. orcid.org/0000-0002-7176-904X, Alexander, S., Brown, S.R. orcid.org/0000-0002-7975-7537 et al. (20 more authors) (2024) Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) – study protocol paper for a phase III multicentre, open-label randomised controlled trial. BMJ Open, 14 (12). e095560. ISSN 2044-6055
Aalbers, J., Akerib, D.S., Al Musalhi, A.K. et al. (200 more authors) (2024) Constraints on covariant dark-matter–nucleon effective field theory interactions from the first science run of the LUX-ZEPLIN experiment. Physical Review Letters, 133. 221801. ISSN 0031-9007
Aalbers, J., Akerib, D.S., Al Musalhi, A.K. et al. (213 more authors) (2024) The data acquisition system of the LZ dark matter detector: FADR. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, 1068. 169712. ISSN 0168-9002
Puttick, C. orcid.org/0009-0006-3022-8737, Jones, T.P. orcid.org/0000-0003-2748-0780, Leung, M.M. orcid.org/0000-0001-9555-1080 et al. (279 more authors) (2024) MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution. Nature Genetics, 56. pp. 2121-2131. ISSN 1061-4036
Aalbers, J., Akerib, D.S., Al Musalhi, A.K. et al. (201 more authors) (2024) Probing the scalar WIMP-pion coupling with the first LUX-ZEPLIN data. Communications Physics, 7 (1). 292. ISSN 2399-3650
Aalbers, J., Akerib, D.S., Al Musalhi, A.K. et al. (201 more authors) (2024) The design, implementation, and performance of the LZ calibration systems. Journal of Instrumentation, 19. P08027.
Carter, M. orcid.org/0000-0003-0683-3874 (2024) The Person as Environmentally Integrated. Journal of Ethics and Social Philosophy, 28 (1). pp. 53-82. ISSN 1559-3061
Hobor, S., Al Bakir, M. orcid.org/0000-0002-0846-8332, Hiley, C.T. et al. (292 more authors) (2024) Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling. Nature Communications, 15. 4871. ISSN 2041-1723
Aalbers, J., Akerib, D.S., Al Musalhi, A.K. et al. (206 more authors) (2024) New constraints on ultraheavy dark matter from the LZ experiment. Physical Review D, 109. 112010. ISSN 2470-0010
Hynds, R.E. orcid.org/0000-0002-2170-8791, Huebner, A. orcid.org/0000-0001-8009-4999, Pearce, D.R. orcid.org/0000-0001-8443-2924 et al. (274 more authors) (2024) Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models. Nature Communications, 15 (1). 4653. ISSN 2041-1723
Aalbers, J., Akerib, D.S., Al Musalhi, A.K. et al. (198 more authors) (2024) First constraints on WIMP-nucleon effective field theory couplings in an extended energy region from LUX-ZEPLIN. Physical Review D, 109 (9). 092003. ISSN 2470-0010
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Pan, X., AbdulJabbar, K. orcid.org/0000-0002-4411-4435, Coelho-Lima, J. et al. (276 more authors) (2024) The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma. Nature Cancer, 5 (2). pp. 347-363. ISSN 2662-1347
Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587
Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736
Ng, K.W., Boumelha, J., Enfield, K.S.S. orcid.org/0000-0002-4551-6073 et al. (328 more authors) (2023) Antibodies against endogenous retroviruses promote lung cancer immunotherapy. Nature, 616. pp. 563-573. ISSN 0028-0836
Martínez-Ruiz, C. orcid.org/0000-0002-4817-0565, Black, J.R.M., Puttick, C. et al. (294 more authors) (2023) Genomic–transcriptomic evolution in lung cancer and metastasis. Nature, 616. pp. 543-552. ISSN 0028-0836
Abbosh, C. orcid.org/0000-0002-8983-1382, Frankell, A.M. orcid.org/0000-0002-0341-7878, Harrison, T. et al. (303 more authors) (2023) Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA. Nature, 616 (7957). pp. 553-562. ISSN 0028-0836
Frankell, A.M. orcid.org/0000-0002-0341-7878, Dietzen, M. orcid.org/0000-0002-6853-7563, Al Bakir, M. orcid.org/0000-0002-0846-8332 et al. (284 more authors) (2023) The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature, 616. pp. 525-533. ISSN 0028-0836
Al Bakir, M. orcid.org/0000-0002-0846-8332, Huebner, A. orcid.org/0000-0001-8009-4999, Martínez-Ruiz, C. orcid.org/0000-0002-4817-0565 et al. (283 more authors) (2023) The evolution of non-small cell lung cancer metastases in TRACERx. Nature, 616. pp. 534-542. ISSN 0028-0836
Carter, M. orcid.org/0000-0003-0683-3874 (2023) Minority Minds: Mental Disability and the Presumption of Value Neutrality. Journal of Applied Philosophy, 40 (2). pp. 358-375. ISSN 0264-3758
Hill, W., Lim, E.L., Weeden, C.E. et al. (323 more authors) (2023) Lung adenocarcinoma promotion by air pollutants. Nature, 616 (7955). pp. 159-167. ISSN 0028-0836
Al-Sawaf, O. orcid.org/0000-0001-9895-0570, Weiss, J., Skrzypski, M. et al. (302 more authors) (2023) Body composition and lung cancer-associated cachexia in TRACERx. Nature Medicine, 29 (4). pp. 846-858. ISSN 1078-8956
Karasaki, T. orcid.org/0000-0001-6863-2360, Moore, D.A. orcid.org/0000-0002-6296-1312, Veeriah, S. et al. (288 more authors) (2023) Evolutionary characterization of lung adenocarcinoma morphology in TRACERx. Nature Medicine, 29 (4). pp. 833-845. ISSN 1078-8956
Carter, M. orcid.org/0000-0003-0683-3874 (2023) The imperative of professional dementia care. Bioethics, 37 (3). pp. 292-302. ISSN 0269-9702
Carter, M. orcid.org/0000-0003-0683-3874 (2022) The Indirect Approach: Towards Non-Dominating Dementia Care. Res Publica, 28 (3). pp. 467-480. ISSN 1356-4765
Wu, Y. orcid.org/0000-0003-4080-3935, Biswas, D. orcid.org/0000-0001-9141-5188, Usaite, I. et al. (302 more authors) (2022) A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer. Nature Cancer, 3. pp. 696-709. ISSN 2662-1347
Carter, M. orcid.org/0000-0003-0683-3874 (2022) Trans Women Are (or Are Becoming) Female: Disputing the Endogeneity Constraint. Hypatia, 37 (2). pp. 384-401. ISSN 0887-5367
Carter, M. orcid.org/0000-0003-0683-3874 (2022) Advance Directives: The Principle of Determining Authenticity. The Hastings Center Report, 52 (1). pp. 32-41. ISSN 0093-0334
Carter, M. orcid.org/0000-0003-0683-3874 (2021) Grief, trauma and mistaken identity: Ethically deceiving people living with dementia in complex cases. Bioethics, 35 (9). pp. 850-856. ISSN 0269-9702
Khorasanee, K. and Carter, M. orcid.org/0000-0003-0683-3874 (2021) Supported Voting: A How‐To Guide. Journal of Applied Philosophy, 38 (4). pp. 674-685. ISSN 0264-3758
Zhang, S.M., Desroses, M., Hagenkort, A. et al. (34 more authors) (2020) Development of a chemical probe against NUDT15. Nature Chemical Biology, 16 (10). pp. 1120-1128. ISSN 1552-4450
Carter, M. orcid.org/0000-0003-0683-3874 (2020) Ethical Deception? Responding to Parallel Subjectivities in People Living with Dementia. Disability Studies Quarterly, 40 (3). ISSN 1041-5718
Jemth, A.-S. orcid.org/0000-0002-7550-1833, Scaletti, E., Carter, M. et al. (2 more authors) (2019) Crystal structure and substrate specificity of the 8-oxo-dGTP hydrolase NUDT1 from Arabidopsis thaliana. Biochemistry, 58 (7). pp. 887-899. ISSN 0006-2960
Gianfrancesco, C. orcid.org/0000-0001-5966-8871, Darwin, Z., McGowan, L. et al. (8 more authors) (2018) Exploring the Feasibility of Use of An Online Dietary Assessment Tool (myfood24) in Women with Gestational Diabetes. Nutrients, 10 (9). 1147. ISSN 2072-6643
Carter, M., Jemth, A.-S., Carreras-Puigvert, J. et al. (6 more authors) (2018) Human NUDT22 is a UDP-glucose/galactose hydrolase exhibiting a unique structural fold. Structure, 26 (2). 295-303.e6. ISSN 0969-2126
Page, B.D.G., Valerie, N.C.K., Wright, R.H.G. et al. (22 more authors) (2018) Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells. Nature Communications, 9 (1). 250. ISSN 2041-1723
Carreras-Puigvert, J., Zitnik, M., Jemth, A.-S. et al. (21 more authors) (2017) A comprehensive structural, biochemical and biological profiling of the human NUDIX hydrolase family. Nature Communications, 8 (1). 1541. ISSN 2041-1723
Valerie, N.C.K., Hagenkort, A., Page, B.D.G. et al. (10 more authors) (2016) NUDT15 hydrolyzes 6-thio-deoxyGTP to mediate the anticancer efficacy of 6-thioguanine. Cancer Research, 76 (18). pp. 5501-5511. ISSN 0008-5472
Carter, M., Jemth, A.-S., Hagenkort, A. et al. (10 more authors) (2015) Crystal structure, biochemical and cellular activities demonstrate separate functions of MTH1 and MTH2. Nature Communications, 6. 7871.